Atebiva 200 mg/25 mg Tablets
PDF Leaflet Revision Date: 24/10/2023
Clinical Summary
Quick overview from the medicine insert
Indication
For the treatment of HIV-1 in adults and adolescents.
Dosage (summary)
200 mg/25 mg once daily for adults and adolescents u2265 12 years and u2265 35 kg.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; avoid breastfeeding.
Key Drug Interactions
- Anticonvulsants
- Antimycobacterials
- St. John's wort
Contraindications
- Hypersensitivity to active substances
Common side effects
- Nausea
- Diarrhoea
- Headache
Counselling Points
- Take once daily with or without food
- Monitor for liver function
- Use effective contraception
Serious warnings
- Lactic acidosis
- Severe hepatotoxicity
- Immune reactivation syndrome
Important Disclaimer
The Atebiva 200 mg/25 mg Tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
